Home
Treatments ▾
Why Transcend ▾
Our Team
Your Journey ▾
Resources ▾
Contact Us(888) 413-7205

Ibogaine for PTSD: What the Research Says, Who Is Screened Out, and What a Stay Looks Like

T
September 4, 2022· 8 min read
Ibogaine for PTSD: What the Research Says, Who Is Screened Out, and What a Stay Looks Like

Short answer: Ibogaine is being studied for PTSD, mostly in veterans, but it isn't FDA-approved and it is Schedule I in the US, so it is not a proven PTSD treatment. If you are weighing it, the questions that matter most are what the published research actually covers, whether your heart and medical history make you a safe candidate, and who is watching you during treatment.

This article is general information, not medical advice. Talk with your own doctor before making any decision about treatment.

If you are in crisis right now, call or text 988 (Suicide & Crisis Lifeline, US). Veterans can call 988 and press 1.

Why do people search for ibogaine for PTSD?

PTSD and substance use often show up together. Trauma can drive drinking or drug use, and substance use can make trauma symptoms harder to manage. Many people looking at ibogaine are dealing with both at once, and they have often already tried talk therapy and prescription medication.

That is why research news about ibogaine and veterans gets so much attention. It is also why it pays to read that research carefully instead of reading the headlines.

What does the research on ibogaine for PTSD actually say?

The most cited study is from Stanford Medicine researchers led by Dr. Nolan Williams, published in Nature Medicine in January 2024 (Cherian et al., doi:10.1038/s41591-023-02705-w). Here is what it was:

  • It looked at magnesium-ibogaine in 30 US special operations veterans with traumatic brain injury, many of whom also reported PTSD symptoms.
  • Treatment was given at Ambio Life Sciences in Mexico, with the veterans' group VETS. Stanford researchers observed and assessed the cohort. Transcend Clinic was not involved.
  • It was open-label, with no control group, and the sample was almost all men.
  • Ambio co-authors are shareholders in Ambio, and Stanford authors hold related patent applications.

A 12-month follow-up of the same cohort was published online in Translational Psychiatry in August 2026 (Faerman, Lissemore et al., doi:10.1038/s41398-026-04327-5) as an accelerated article preview. Stanford Medicine covered it in October 2026 (med.stanford.edu/news).

What this means for you: these are early, uncontrolled studies in a narrow group. They are reasons to keep studying ibogaine, not evidence that it will work for you. Broader reviews, such as Kervadec et al., "Thirty Years of Ibogaine Research" (J Clin Psychopharmacol, 2026, doi:10.1097/JCP.0000000000002197), also cover the safety record, including cardiac risk. We don't restate any study's results as our own, and no study predicts your outcome.

No. Ibogaine isn't FDA-approved for PTSD or any other condition, and it is Schedule I in the US. Some states have funded research, but that does not make treatment legal or available in the US. People who choose ibogaine travel to clinics outside the US, such as Transcend Clinic in Cancún, Mexico.

Who is screened out?

Safety starts with the heart. Ibogaine carries known cardiac risks, which is why thorough medical screening is essential.

Certain heart, lung, or liver conditions may affect eligibility, so we encourage you to share your medical records as early as possible to help us assess your suitability for treatment.

Certain medical conditions including some heart and lung issues may make ibogaine treatment unsuitable, and our screening process is designed to ensure that only appropriate candidates proceed.

Substance use matters too. Tell us about every substance you use. If you use more than one drug, tell us all of them at intake. If you drink heavily or regularly, please do not stop abruptly without medical guidance, as alcohol withdrawal can be dangerous and potentially life-threatening.

Not sure where you stand? Start with Is Ibogaine Right for You?.

How does screening work? Step by step

  1. Share your history before you book. Before you travel, our medical team carefully reviews your medical history, current medications, and any relevant health conditions.
  2. List every medication and supplement. To help us assess your eligibility, please have a complete list of all medications and supplements available during your initial consultation.
  3. Be honest about substance use. Our intake team will ask about your medications and history.
  4. Testing on arrival. Upon arrival at the clinic, a 12-lead electrocardiogram (ECG) and comprehensive blood tests are performed.
  5. Cardiology clearance. Final medical clearance for treatment is granted by our in-house cardiologist after reviewing these results and completing a cardiovascular assessment.
  6. Supervised treatment. Throughout treatment, patients receive 24/7 on-site medical supervision, allowing our experienced team to recognize and promptly address potential complications.

Every patient goes through a complete medical evaluation before treatment. See the full intake process.

What does a stay look like?

Transcend Clinic is in Cancún, Mexico, with licensed physicians and a cardiologist on staff. Your stay is built around the screening above, supervised treatment, and time to rest afterward. Our medical team reviews your history and health at intake and confirms the program length and fee before booking.

For details on our PTSD and trauma program, see PTSD & Trauma treatment. Veterans and first responders could qualify for special programs; ask our intake team.

Checklist: before you contact any ibogaine clinic

  • I've read that ibogaine isn't FDA-approved and is Schedule I in the US.
  • I've talked with my own doctor or therapist about it.
  • I have my medical records ready, including any heart, lung or liver history.
  • I have a full list of medications and supplements.
  • I've listed every substance I use, including alcohol.
  • I've asked the clinic whether an ECG and blood tests happen on arrival.
  • I've asked who gives final medical clearance.
  • I've asked whether there is 24/7 on-site medical supervision.
  • I've asked whether licensed physicians are on site.
  • I've checked that any research the clinic cites was actually done at that clinic.
  • I have a crisis plan, including 988, before and after travel.

Table: questions to ask, and how Transcend answers

Question to ask a clinic Why it matters Transcend Clinic
Is there medical screening before travel? Ibogaine carries known cardiac risks Our medical team reviews your history, medications and health conditions before you travel
What tests happen on arrival? Confirms you are still a safe candidate 12-lead ECG and comprehensive blood tests
Who gives final clearance? A specialist should sign off on cardiac risk Our in-house cardiologist, after a cardiovascular assessment
Who supervises treatment? Complications need fast response 24/7 on-site medical supervision
Who is on the medical team? Credentials matter Licensed physicians and a cardiologist on staff
Was the research they cite done there? Avoid borrowed credibility The Stanford study was done at Ambio Life Sciences, not Transcend

FAQ

Is ibogaine approved for PTSD? No. Ibogaine isn't FDA-approved for PTSD or any condition, and it is Schedule I in the US. Research is ongoing.

Did Stanford treat veterans with ibogaine? Stanford Medicine researchers studied veterans who were treated at Ambio Life Sciences in Mexico. Stanford observed and assessed the group; the treatment itself was at Ambio.

Is ibogaine safe for everyone with PTSD? No. Ibogaine carries known cardiac risks, which is why thorough medical screening is essential. Certain heart, lung, or liver conditions may affect eligibility.

What happens if I drink heavily? Please do not stop abruptly without medical guidance, as alcohol withdrawal can be dangerous and potentially life-threatening. Tell our intake team how much and how often you drink.

Who will be watching me during treatment? Throughout treatment, patients receive 24/7 on-site medical supervision, allowing our experienced team to recognize and promptly address potential complications.

Talk to our intake team

If you want to know whether you might be a candidate, contact our intake team or email support@transcendibogaine.com. You can also chat with Lisa, our AI advisor, on transcendclinic.com.

Toll-free: (888) 413-7205 · US/Canada: +1 (760) 621-6203 · Cancún: +52 998 281 6506

Not medical advice. Ibogaine isn't FDA-approved and is Schedule I in the US. In crisis, call or text 988.

T
Written by
Clinical & Editorial Staff
Medical and editorial team at Transcend Ibogaine Treatment Center.
Related Articles
Ibogaine Treatment for Parkinson's Disease
→
Ibogaine Treatment For Bipolar Disorder
→
Dexedrine Abuse and Addiction Treatment of the ADHD Medication
→
← Back to Blog